These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8436543)

  • 1. Tetronothiodin, a novel cholecystokinin type-B receptor antagonist produced by Streptomyces sp. NR0489. II. Isolation, characterization and biological activities.
    Ohtsuka T; Kotaki H; Nakayama N; Itezono Y; Shimma N; Kudoh T; Kuwahara T; Arisawa M; Yokose K; Seto H
    J Antibiot (Tokyo); 1993 Jan; 46(1):11-7. PubMed ID: 8436543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetronothiodin, a novel CCKB receptor ligand, antagonizes cholecystokinin-induced Ca2+ mobilization in a pituitary cell line.
    Kuwahara T; Kudoh T; Nagase H; Takamiya M; Nakano A; Ohtsuka T; Yoshizaki H; Arisawa M
    Eur J Pharmacol; 1992 Oct; 221(1):99-105. PubMed ID: 1459194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetronothiodin, a novel cholecystokinin type-B receptor antagonist produced by Streptomyces sp. NR0489. I. Taxonomy, yield improvement and fermentation.
    Watanabe J; Fujisaki N; Fujimori K; Anzai Y; Oshima S; Sano T; Ohtsuka T; Watanabe K; Okuda T
    J Antibiot (Tokyo); 1993 Jan; 46(1):1-10. PubMed ID: 8436542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetronothiodin, a novel cholecystokinin type-B receptor antagonist produced by Streptomyces sp.
    Ohtsuka T; Kudoh T; Shimma N; Kotaki H; Nakayama N; Itezono Y; Fujisaki N; Watanabe J; Yokose K; Seto H
    J Antibiot (Tokyo); 1992 Jan; 45(1):140-3. PubMed ID: 1548186
    [No Abstract]   [Full Text] [Related]  

  • 5. Tetronothiodin, a novel cholecystokinin type-B receptor antagonist produced by Streptomyces sp. NR0489. III. Structural elucidation.
    Ohtsuka T; Nakayama N; Itezono Y; Shimma N; Kuwahara T; Yokose K; Seto H
    J Antibiot (Tokyo); 1993 Jan; 46(1):18-24. PubMed ID: 8436552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species specificity of pharmacological characteristics of CCK-B receptors.
    Kuwahara T; Kudoh T; Nakano A; Yoshizaki H; Takamiya M; Nagase H; Arisawa M
    Neurosci Lett; 1993 Aug; 158(1):1-4. PubMed ID: 8233061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of CCK-B receptors elevates cytosolic Ca2+ levels in a pituitary cell line.
    Kuwahara T; Nagase H; Takamiya M; Yoshizaki H; Kudoh T; Nakano A; Arisawa M
    Peptides; 1993; 14(4):801-5. PubMed ID: 8234029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of CCKB receptors on GH3 pituitary cells: receptor activation is linked to Ca2+ mobilisation.
    Smith AJ; Patel S; Freedman SB
    Eur J Pharmacol; 1994 Apr; 267(2):215-23. PubMed ID: 8050481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of YM022: its CCKB/gastrin receptor binding profile and antagonism to CCK-8-induced Ca2+ mobilization.
    Saita Y; Yazawa H; Honma Y; Nishida A; Miyata K; Honda K
    Eur J Pharmacol; 1994 Oct; 269(2):249-54. PubMed ID: 7851501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological characterization of rebamipide: its cholecystokinin CCK1 receptor binding profile and effects on Ca2+ mobilization and amylase release in rat pancreatic acinar cells.
    Moon SJ; An JM; Kim J; Lee SI; Ahn W; Kim KH; Seo JT
    Eur J Pharmacol; 2004 Nov; 505(1-3):61-6. PubMed ID: 15556137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte cell line.
    Lignon MF; Bernad N; Martinez J
    Eur J Pharmacol; 1993 May; 245(3):241-6. PubMed ID: 8335062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
    Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
    Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological profile of TP-680, a new cholecystokininA receptor antagonist.
    Akiyama T; Tachibana I; Hirohata Y; Shirohara H; Yamamoto M; Otsuki M
    Br J Pharmacol; 1996 Apr; 117(7):1558-64. PubMed ID: 8730754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCKB receptor signaling in rat pituitary GH3 cells. CCK-8S-induced intracellular calcium mobilization by Ca2+ release and Ca2+ influx.
    Kaufmann R; Lindschau C; Schöneberg T; Henklein P; Boomgaarden M; Haller H; Ott T
    Neuropeptides; 1994 Oct; 27(4):211-6. PubMed ID: 7808593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the states and populations of the rat pancreatic cholecystokinin receptor using the full peptide antagonist JMV 179.
    Silvente Poirot S; Hadjiivanova C; Escrieut C; Dufresne M; Martinez J; Vaysse N; Fourmy D
    Eur J Biochem; 1993 Mar; 212(2):529-38. PubMed ID: 8444190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paracrine stimulation of cell growth by cholecystokinin/gastrin through cholecystokinin-B receptor on GH3 cells in vitro.
    Xu Y; Kaji H; Okimura Y; Matsui T; Abe H; Chihara K
    Neuroendocrinology; 1996 Oct; 64(4):280-5. PubMed ID: 8895857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a new diphenylpyrazolidinone cholecystokinin antagonist in vitro isolated rat pancreatic acini.
    Akiyama T; Tachibana I; Otsuki M
    Int J Pancreatol; 1993 Oct; 14(2):167-73. PubMed ID: 7506744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GH3 cells, an anterior pituitary cell line, express CCK-B receptors.
    Kuwahara T; Takamiya M; Nagase H; Kudoh T; Nakano A; Yoshizaki H; Arisawa M
    Peptides; 1993; 14(3):647-9. PubMed ID: 8332561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin-8 stimulates adrenocorticotropin release from anterior pituitary cells.
    Reisine T; Jensen R
    J Pharmacol Exp Ther; 1986 Mar; 236(3):621-6. PubMed ID: 2419542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.